open access
The role of cardiometabolic risk factors and endothelial dysfunction in serum albumin levels of patients with COVID-19
, 1, 1, 13, 2, 4, 4, 4, 1, 1, 1, 2, 1
Affiliations- 3rd Department of Cardiology, National and Kapodistrian University of Athens, Medical School, Sotiria Chest Disease Hospital, Athens, Greece
- 1st Department of Cardiology, National and Kapodistrian University of Athens, Medical School, Hippokration General Hospital, Athens, Greece
- Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States
- 2nd Cardiology Department, Echocardiography Department and Laboratory of Preventive Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
open access
Abstract
Abstract
About this articleTitle
The role of cardiometabolic risk factors and endothelial dysfunction in serum albumin levels of patients with COVID-19
Journal
Issue
Article type
Research Letter
Pages
1037-1039
Published online
2022-09-16
Page views
3399
Article views/downloads
367
DOI
10.5603/CJ.a2022.0088
Pubmed
Bibliographic record
Cardiol J 2022;29(6):1037-1039.
Authors
Evangelos Oikonomou
Nektarios Souvaliotis
Stamatios Lampsas
Gerasimos Siasos
Panagiotis Theofilis
Emmanouil Korakas
Vaia Lambadiari
Ignatios Ikonomidis
Theodoros Pesiridis
Georgios Zakynthinos
Ourania Katsarou
Dimitris Tousoulis
Manolis Vavouranakis
References (10)- Wagner J, Garcia-Rodriguez V, Yu A, et al. Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity. Sci Rep. 2021; 11(1): 10308.
- Knox DB, Lee V, Leither L, et al. New-Onset systemic capillary leak syndrome in an adult patient with COVID-19. Case Rep Crit Care. 2021; 2021: 8098942.
- Lacout C, Rogez J, Orvain C, et al. A new diagnosis of systemic capillary leak syndrome in a patient with COVID-19. Rheumatology (Oxford). 2021; 60(1): e19–e20.
- Del Turco S, Gaggini M, Daniele G, et al. Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk. Curr Pharm Des. 2013; 19(13): 2420–2431.
- Janus A, Szahidewicz-Krupska E, Mazur G, et al. Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders. Mediators Inflamm. 2016; 2016: 3634948.
- Oikonomou E, Souvaliotis N, Lampsas S, et al. Endothelial dysfunction in acute and long standing COVID-19: A prospective cohort study. Vascul Pharmacol. 2022; 144: 106975.
- Lampsas S, Tsaplaris P, Pantelidis P, et al. The role of endothelial related circulating biomarkers in COVID-19. A systematic review and meta-analysis. Curr Med Chem. 2022; 29(21): 3790–3805.
- Sagris M, Theofilis P, Antonopoulos AS, et al. Inflammatory mechanisms in COVID-19 and atherosclerosis: current pharmaceutical perspectives. Int J Mol Sci. 2021; 22(12).
- Soetedjo NN, Iryaningrum MR, Damara FA, et al. Prognostic properties of hypoalbuminemia in COVID-19 patients: A systematic review and diagnostic meta-analysis. Clin Nutr ESPEN. 2021; 45: 120–126.
- Huang J, Cheng A, Kumar R, et al. Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity. J Med Virol. 2020; 92(10): 2152–2158.
